Antitumor necrosis α treatment in primary sclerosing cholangitis associated inflammatory bowel disease after liver transplantation.

Subjects

Subjects :

Adult
Cholangitis, Sclerosing etiology
Female
Follow-Up Studies
Humans
Inflammatory Bowel Diseases drug therapy
Male
Middle Aged
Prospective Studies
Time Factors
Treatment Outcome
Biological Factors therapeutic use
Cholangitis, Sclerosing drug therapy
Inflammatory Bowel Diseases complications
Liver Transplantation adverse effects
Postoperative Complications
Tumor Necrosis Factor-alpha antagonists & inhibitors

Details

Language :

English

ISSN :

1527-6473

Volume :

21

Issue :

11

Database :

MEDLINE

Journal :

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Publication Type :

Editorial & Opinion

Accession number :

26175058

Full Text :

https://doi.org/10.1002/lt.24212